drugset / Trial / NCT06967194

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

NCT06967194

Recruiting 200 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is looking at how a medication called beta-blockers (metoprolol) affects patients with a heart attack (STEMI) who are in the cardiac intensive care unit. When patients are admitted to the unit, they will be randomly placed in one of two groups. One group will get the metoprolol medication, and the other will receive a placebo (a harmless pill that looks like the real medication). All other treatments will be the same for both groups. During the study, which is 72 hours long, patients will be monitored for blood pressure, heart rate, and lactate levels alterations. The main goal is to see if the medication helps improve patients condition or prevent it from getting worse. patients safety is a top priority, and if needed, the doctors can stop the study at any time if there are concerns.

Timeline

Start
2025-05-21
Primary completion
2027-05
Completion
2027-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 25 mg